Big Money Issues Come Up Next Week at CIRM
A key panel of directors of the California stem cell agency next week will tackle three hefty financial topics, ranging from its proposed $500 million biotech loan program to the amount of money available for grants and loans.
No details of what is to be considered are yet available on the CIRM website for the Sept. 12 meeting of the Finance Subcommittee
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.